Carl Ola Landgren, Md, Phd

This study is testing whether two different drug combinations can delay or prevent the development of active multiple myeloma in people with high-risk early-stage disease. The trial will enroll 50 adults with smoldering myeloma who haven't received prior treatment. Researchers wi…